Table 6.
Compd | R1 | R2 | MIC | CC50 [b] | |||
---|---|---|---|---|---|---|---|
μg mL−1 | μm | μg mL−1 | μm | ||||
34 a | H | 0.62 | 1.5 | 4.0 | 9.6 | ||
34 b | Br | 1.6 | 3.7 | 11 | 25.4 | ||
34 c | Br | 2.5 | 5.6 | 7.8 | 17.4 | ||
34 d | Br | 2.0 | 4.3 | 12 | 26.0 | ||
34 e | Br | 0.81 | 1.7 | 6.2 | 12.9 | ||
34 f | Br | 0.58 | 1.2 | 4.4 | 9.2 | ||
34 g | Br | 5.2 | 10.9 | 5.6 | 11.7 | ||
34 h | Br | 0.72 | 1.5 | 7.4 | 15.9 | ||
34 i | Br | 0.55 | 1.1 | 11 | 22.9 | ||
34 j | Br | 1.5 | 3.1 | 4.2 | 8.7 | ||
34 k | Br | 0.89 | 1.7 | 14 | 26.8 | ||
34 l | Br | 0.79 | 1.5 | 5.0 | 9.3 | ||
34 m | Br | 0.43 | 0.95 | 3.0 | 6.7 | ||
34 n | Br | 0.71 | 1.5 | 9.7 | 20.9 | ||
34 o | Br | 1.6 | 3.9 | 12 | 29.4 | ||
34 p | Br | 5.9 | 15.9 | 17 | 45.8 |
[a] Reference compound: bedaquiline MIC=0.060 μg mL−1 (0.1 μm). [b] Concentration at which the growth of Vero cells is inhibited by 50 %.